Bristol-Myers Squibb (BMY) Stock Forecast for 2024, 2025, 2026. Sell or Buy Prediction







A Comprehensive Guide to RoadRunner Auto Transport Services

October 22, 2024 A Comprehensive Guide to RoadRunner Auto Transport Services

If you want to ship your car from one city to another, why not hire the experts to do everything for you? They…
Mastering Trading Indicators: Your Essential Toolkit For Success

October 3, 2024 Mastering Trading Indicators: Your Essential Toolkit For Success

Often investors struggle to identify profitable trades consistently. Trading indicators provide essential data to guide trading decisions. This article explains key indicators and…
Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…

Bristol-Myers (BMY) Stock Forecast for 2024, 2025, 2026. Sell or Buy?

Updated: December 5, 2024 (08:43)

Sector: Healthcare

The share price of Bristol-Myers Squibb Company (BMY) now

Latest session on the 4th of December for
Bristol-Myers Squibb Company is negative
Trading Volume: 9533695
Open: 58.57 /  High: 58.79 /  Low: 57.59
What analysts predict: $60.43
52-week High/Low: $61.08 / $38.6
50-Day Moving Average: $54.41 — support level today
200-Day Moving Average: $48.73 — support level today

Are you interested in Bristol-Myers Squibb Company stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Bristol-Myers stock price in 2025, 2026, 2027. How much will one Bristol-Myers share be worth in 2025 - 2027?

When should I take profit in Bristol-Myers stock? When should I record a loss on Bristol-Myers stock? What are analysts' forecasts for Bristol-Myers stock? What is the future of Bristol-Myers stock? We forecast Bristol-Myers stock performance using neural networks based on historical data on Bristol-Myers stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Bristol-Myers stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Bristol-Myers shares. This happens once a day.


Historical and forecast chart of Bristol-Myers stock

The chart below shows the historical price of Bristol-Myers stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Bristol-Myers stock price can be found in the table below.

Long-term forecasts by years.

Bristol-Myers Squibb is an American pharmaceutical company. Develops drugs in various areas of medicine, including: oncology, HIV / acquired immunodeficiency syndrome, cardiovascular diseases, diabetes, hepatitis B and C, rheumatoid arthritis and mental disorders. The mission of the company is to discover, develop and supply innovative medicines to patients so that they can overcome serious illnesses. The mission also means that the company is working to ensure that patients have access to healthcare through public and private partners. The firm’s strategy combines the scale and resources of a large pharmaceutical corporation with the entrepreneurial spirit and agility of a successful biotech firm.

Bristol-Myers Squibb started out as two different companies – Bristol-Myers and Squibb. The Squibb Corporation was formed in 1858 in Brooklyn, New York. Founder Edward Robinson Squibb was a preeminent proponent of quality control and high purity standards within the emerging pharmaceutical industry of his day. After a failed attempt to convince the American Medical Association to accept higher frequency standards, he independently published an alternative to the US Pharmacopoeia (Squibb’s Ephemeris of Materia Medica). In 1887, Hamilton College alumni William McLaren Bristol and John Ripley Myers bought Clinton Pharmaceutical from Clinton, Oneida County, New York. After Myers’ death in 1899, Bristol changed its name to Bristol-Myers Corporation. The first nationally recognized product was Sal Hepatica, a laxative mineral salt in 1903. Its second national success was the Ipana toothpaste, from 1901 to 1960. The second national success was with Ipana toothpaste, from 1901 to 1960. Bristol-Myers and Squibb merged to form Bristol-Myers Squibb in 1989.

Official site of the company

Trending Themes in the Healthcare Sector

Bristol-Myers daily forecast for a month

Date Target Pes. Opt. Vol., %
Dec 07 59.31 58.91 59.61 1.19
Dec 08 59.09 58.86 59.28 0.71
Dec 09 58.91 58.74 59.32 0.99
Dec 10 58.53 58.22 58.65 0.73
Dec 11 58.66 58.34 58.90 0.97
Dec 12 58.85 58.60 59.08 0.81
Dec 13 59.10 58.90 59.44 0.91
Dec 14 59.02 58.72 59.36 1.10
Dec 15 59.34 59.20 59.51 0.52
Dec 16 59.01 58.58 59.46 1.49
Dec 17 59.23 59.02 59.39 0.62
Dec 18 59.61 59.19 59.75 0.94
Dec 19 59.74 59.30 59.91 1.03
Dec 20 59.96 59.61 60.12 0.87
Dec 21 60.07 59.78 60.44 1.12
Dec 22 60.52 60.05 60.70 1.09
Dec 23 60.94 60.55 61.37 1.34
Dec 24 60.90 60.46 61.24 1.30
Dec 25 60.34 60.08 60.57 0.81
Dec 26 60.06 59.76 60.24 0.81
Dec 27 59.93 59.74 60.21 0.79
Dec 28 60.06 59.76 60.41 1.09
Dec 29 60.35 60.07 60.79 1.19
Dec 30 60.47 60.13 60.74 1.02
Dec 31 60.47 60.16 60.62 0.77
Jan 01 60.28 60.00 60.42 0.69
Jan 02 60.00 59.77 60.15 0.63
Jan 03 60.10 59.88 60.51 1.05
Jan 04 59.77 59.62 59.93 0.51
Jan 05 59.19 59.08 59.54 0.78

Bristol-Myers Daily Price Targets


Bristol-Myers Stock Forecast 12-07-2024.

Forecast target price for 12-07-2024: $59.31.
Positive dynamics for Bristol-Myers shares will prevail with possible volatility of 1.174%.
Pessimistic target level: 58.91
Optimistic target level: 59.61

Bristol-Myers Stock Forecast 12-08-2024.

Forecast target price for 12-08-2024: $59.09.
Negative dynamics for Bristol-Myers shares will prevail with possible volatility of 0.708%.
Pessimistic target level: 58.86
Optimistic target level: 59.28

Bristol-Myers Stock Forecast 12-09-2024.

Forecast target price for 12-09-2024: $58.91.
Negative dynamics for Bristol-Myers shares will prevail with possible volatility of 0.983%.
Pessimistic target level: 58.74
Optimistic target level: 59.32

Bristol-Myers Stock Forecast 12-10-2024.

Forecast target price for 12-10-2024: $58.53.
Negative dynamics for Bristol-Myers shares will prevail with possible volatility of 0.729%.
Pessimistic target level: 58.22
Optimistic target level: 58.65

Bristol-Myers Stock Forecast 12-11-2024.

Forecast target price for 12-11-2024: $58.66.
Positive dynamics for Bristol-Myers shares will prevail with possible volatility of 0.956%.
Pessimistic target level: 58.34
Optimistic target level: 58.90

Bristol-Myers Stock Forecast 12-12-2024.

Forecast target price for 12-12-2024: $58.85.
Positive dynamics for Bristol-Myers shares will prevail with possible volatility of 0.807%.
Pessimistic target level: 58.60
Optimistic target level: 59.08

BMY (BMY) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan. 58.42 56.43 59.09 4.50
Feb. 57.78 56.54 59.51 5.00
Mar. 57.75 56.65 59.80 5.26
Apr. 58.04 56.50 59.40 4.89
May. 56.88 54.66 57.62 5.13
Jun. 58.70 57.73 60.40 4.42
Jul. 58.26 57.35 58.93 2.67
Aug. 59.54 57.40 61.74 7.04
Sep. 60.52 58.92 62.28 5.39
Oct. 58.25 57.12 60.41 5.45
Nov. 59.47 57.33 60.28 4.88
Dec. 57.13 55.33 58.78 5.88

Bristol-Myers forecast for this year


Bristol-Myers Stock Prediction for Jan 2025

An uptrend is forecast for this month with an optimal target price of $58.4205. Pessimistic: $56.43. Optimistic: $59.09


Bristol-Myers Stock Prediction for Feb 2025

An downtrend is forecast for this month with an optimal target price of $57.7779. Pessimistic: $56.54. Optimistic: $59.51


Bristol-Myers Stock Prediction for Mar 2025

An downtrend is forecast for this month with an optimal target price of $57.749. Pessimistic: $56.65. Optimistic: $59.80


Bristol-Myers Stock Prediction for Apr 2025

An uptrend is forecast for this month with an optimal target price of $58.0378. Pessimistic: $56.50. Optimistic: $59.40


Bristol-Myers Stock Prediction for May 2025

An downtrend is forecast for this month with an optimal target price of $56.877. Pessimistic: $54.66. Optimistic: $57.62


Bristol-Myers Stock Prediction for Jun 2025

An uptrend is forecast for this month with an optimal target price of $58.6971. Pessimistic: $57.73. Optimistic: $60.40


Bristol-Myers Stock Prediction for Jul 2025

An downtrend is forecast for this month with an optimal target price of $58.2568. Pessimistic: $57.35. Optimistic: $58.93


Bristol-Myers Stock Prediction for Aug 2025

An uptrend is forecast for this month with an optimal target price of $59.5385. Pessimistic: $57.40. Optimistic: $61.74


Bristol-Myers Stock Prediction for Sep 2025

An uptrend is forecast for this month with an optimal target price of $60.5209. Pessimistic: $58.92. Optimistic: $62.28


Bristol-Myers Stock Prediction for Oct 2025

An downtrend is forecast for this month with an optimal target price of $58.2513. Pessimistic: $57.12. Optimistic: $60.41


Bristol-Myers Stock Prediction for Nov 2025

An uptrend is forecast for this month with an optimal target price of $59.4746. Pessimistic: $57.33. Optimistic: $60.28


Bristol-Myers Stock Prediction for Dec 2025

An downtrend is forecast for this month with an optimal target price of $57.1254. Pessimistic: $55.33. Optimistic: $58.78



Bristol-Myers (BMY) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 58.38 56.40 59.46 5.15
Feb 57.24 56.33 58.25 3.29
Mar 58.13 56.15 59.82 6.12
Apr 57.26 55.34 59.21 6.53
May 59.72 58.08 61.69 5.86
Jun 60.71 59.83 61.95 3.43
Jul 61.37 59.81 62.79 4.74
Aug 59.50 57.84 61.23 5.54
Sep 59.18 57.75 61.54 6.15
Oct 58.91 57.41 59.70 3.85
Nov 57.05 54.83 58.45 6.20
Dec 58.48 57.51 59.44 3.25

Bristol-Myers (BMY) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 60.67 59.97 61.40 2.32
Feb 62.49 60.81 64.31 5.44
Mar 61.52 59.62 63.68 6.38
Apr 59.74 58.63 60.76 3.49
May 58.01 56.85 59.72 4.81
Jun 57.78 56.16 59.02 4.85
Jul 55.96 54.28 56.88 4.57
Aug 58.19 56.01 59.27 5.50
Sep 58.83 57.80 59.80 3.34
Oct 59.95 58.27 62.23 6.36
Nov 58.93 57.81 61.26 5.63
Dec 58.20 56.54 60.26 6.18

Bristol-Myers information and performance

Bristol-Myers Address

430 E. 29TH STREET, 14 FLOOR, NEW YORK, NY, US

Market Capitalization: 120 210 088 000 $

Market capitalization of the Bristol-Myers Squibb Company is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of BMY shares in the company outstanding by the market price of one share.

EBITDA: 19 161 999 000 $

EBITDA of Bristol-Myers is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 2.04

Price/earnings to growth

DPS: 2.4

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: 0.0405

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -3.58

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: -0.358
Quarterly Revenue Growth YOY: 0.084
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 8.36

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 3.445

Enterprise Value (EV) /Revenue

EV To EBITDA: 32.23

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 2028180000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Bristol-Myers (BMY) stock dividend

Bristol-Myers last paid dividends on 10/04/2024. The next scheduled payment will be on 11/01/2024. The amount of dividends is $2.4 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.

Last Split Factor:

Last Split Date: 01/01/1970

Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.

For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.